Hims & Hers Health Inc. sell UBS Group AG
Start price
26.06.25
/
50%
€35.55
Target price
26.06.26
-
Performance (%)
-15.50%
End price
27.06.26
€30.04
Summary
This prediction ended on 27.06.26 with a price of €30.04. The price of Hims & Hers Health Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -15.50%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Hims & Hers Health Inc. | -2.510% | -2.510% | -55.457% |
| iShares Core DAX® | 2,59 % | 2,47 % | 8,84 % |
| iShares Nasdaq 100 | -0,91 % | -6,46 % | 24,93 % |
| iShares Nikkei 225® | 0,15 % | -8,77 % | 47,39 % |
| iShares S&P 500 | -0,37 % | -1,22 % | 21,67 % |
Comments by UBS_Group_AG for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) had its "underperform" rating re-affirmed by analysts at UBS Group AG.
Ratings data for HIMS provided by MarketBeat
In the thread Trading Hims & Hers Health Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten